Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis
CHICAGO — Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022.
IDSA announces courage award honoring Fauci
The Infectious Diseases Society of America on Friday announced the creation of an award honoring National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, MD.
Log in or Sign up for Free to view tailored content for your specialty!
What will be the most significant consequence of long COVID?
Long COVID can cause multisystem health issues that can last anywhere from months to years. We asked Farha S. Ikramuddin, MD, MPH, assistant professor in the department of rehabilitation medicine at the University of Minnesota Medical School, what the most significant consequence of long COVID will be moving forward.
Hooked on ID with David Boulware, MD, MPH
I grew up in a household surrounded by medicine and the medical needs of my sister. It was an environment I had become accustomed to and later became the focal point of my studies.
VIDEO: Incoming IDSA President Carlos del Rio, MD, lays out agenda for next year
WASHINGTON — Carlos del Rio, MD, an Infectious Disease News Editorial Board Member and the new president of the Infectious Diseases Society of America, discussed his agenda with Healio.
Multiple RSV vaccines in late-stage development show promise in older adults
WASHINGTON — Three late-breaking studies offered a promising glimpse of respiratory syncytial virus vaccines in the pipeline for older adults — including the RSVPreF3 OA vaccine, which showed an overall vaccine efficacy of about 83%.
US gives nod to Novavax’s COVID-19 booster as alternative to mRNA shots
The FDA authorized a booster shot of Novavax’s COVID-19 vaccine, giving the United States an option for people who cannot or will not receive a messenger RNA vaccine.
Disease outbreaks linked to adverse mental health issues in adolescents, young people
The COVID-19 pandemic and H1N1 epidemic were associated with adverse mental health events in adolescents and youth from low- and middle-income countries, researchers reported in JAMA Psychiatry.
COVID-19 rebound not due to impaired immune response, small study suggests
COVID-19 rebound in people who have recovered from the disease is not due to an impaired immune response, according to a small study of patients treated with and without Paxlovid.
People with HIV should participate in tuberculosis vaccine trials, new recommendations say
Experts say that people with HIV should be included in clinical trials for new tuberculosis vaccine candidates in the pipeline, according to newly written recommendations published in The Lancet HIV.
-
Headline News
FDA approves nasal spray as first self-administered flu vaccine
September 20, 20241 min read -
Headline News
HHS proposes rule change for HIV-positive organ recipients
September 23, 20241 min read -
Headline News
Cold weather exposure may increase risk for heart attack
September 23, 20242 min read
-
Headline News
FDA approves nasal spray as first self-administered flu vaccine
September 20, 20241 min read -
Headline News
HHS proposes rule change for HIV-positive organ recipients
September 23, 20241 min read -
Headline News
Cold weather exposure may increase risk for heart attack
September 23, 20242 min read